日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

PHAROS 研究最新结果的简明语言摘要:恩考拉非尼联合比美替尼治疗 BRAF V600E 突变型转移性非小细胞肺癌患者

Johnson, Melissa L; Smit, Egbert F; Felip, Enriqueta; Ramalingam, Suresh S; Ahn, Myung-Ju; Tsao, Anne; Johnson, Bruce E; Offin, Michael; Hussein, Maen; Dagogo-Jack, Ibiayi; Goldman, Jonathan W; Clarke, Jeffrey M; Negrao, Marcelo V; Sanborn, Rachel E; Morgensztern, Daniel; Usari, Tiziana; Wilner, Keith; Alejandro, Linh; Rifi, Nada; Zhang, Xiaosong; Riely, Gregory J

Alirocumab plus cemiplimab in advanced immuno-refractory metastatic non-small cell lung cancer: an ongoing multi-center phase II study

Alirocumab联合cemiplimab治疗晚期免疫难治性转移性非小细胞肺癌:一项正在进行的多中心II期研究

Oduah, Eziafa I; Zhang, Tian; Jung, Sin-Ho; Stinchcombe, Thomas E; Ready, Neal; Crawford, Jeffrey; Clarke, Jeffrey M; Gray, Jhanelle E; Antonia, Scott J

Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer

来自 PHAROS II 期研究的最新总生存期分析:恩考拉非尼联合比美替尼治疗 BRAF V600E 突变转移性非小细胞肺癌患者

Johnson, Melissa L; Smit, Egbert F; Felip, Enriqueta; Ramalingam, Suresh S; Ahn, Myung-Ju; Tsao, Anne; Johnson, Bruce E; Offin, Michael; Hussein, Maen; Dagogo-Jack, Ibiayi; Goldman, Jonathan W; Clarke, Jeffrey M; Negrao, Marcelo V; Sanborn, Rachel E; Morgensztern, Daniel; Usari, Tiziana; Wilner, Keith; Alejandro, Linh; Rifi, Nada; Zhang, Xiaosong; Riely, Gregory J

Updated Efficacy and Safety From the Phase 2 PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic NSCLC-A Brief Report

Encorafenib联合Binimetinib治疗BRAF V600E突变转移性非小细胞肺癌患者的II期PHAROS研究的最新疗效和安全性简报

Riely, Gregory J; Ahn, Myung-Ju; Clarke, Jeffrey M; Dagogo-Jack, Ibiayi; Esper, Raymond; Felip, Enriqueta; Gelsomino, Francesco; Goldman, Jonathan W; Hussein, Maen; Johnson, Melissa; Marrone, Kristen A; Morgensztern, Daniel; Nadal, Ernest; Negrao, Marcelo V; Offin, Michael; Provencio, Mariano; Ramalingam, Suresh S; Roof, Logan; Sanborn, Rachel E; Smit, Egbert F; Tsao, Anne; Usari, Tiziana; Alcasid, Ann; Wilner, Keith; Tonkovyd, Svitlana; Zhang, Xiaosong; Johnson, Bruce E

Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity

波齐替尼治疗EGFR 20号外显子插入突变型非小细胞肺癌:II期ZENITH试验的临床疗效及EGFR 20号外显子插入位置对药物敏感性的差异性影响

Le, Xiuning; Robichaux, Jacqulyne P; Nilsson, Monique; Vijayan, R S K; Ravichandran, Ashwin; Wu, Jia; Elamin, Yasir Y; Hong, Lingzhi; Pei, Jun; He, Jun; Patel, Sonia; Udagawa, Hibiki; Mani, Sriramvignesh; Jang, Chang Woon; Clarke, Jeffrey M; Tchekmedyian, Nishan; Goldman, Jonathan W; Socinski, Mark; Bhat, Gajanan; Leu, Sharon; Bunn, Veronica; Su, Zhenqiang; Vincent, Sylvie; Lawson, John W; Cross, Jason B; Heymach, John V

Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

针对补体因子 H 的抗体 GT103 在难治性非小细胞肺癌中的应用:一项 1b 期剂量递增试验

Clarke Jeffrey M, Simon George R, Mamdani Hirva, Gu Lin, Herndon James E 2nd, Stinchcombe Thomas E, Ready Neal, Crawford Jeffrey, Sonpavde Guru, Balevic Stephen, Nixon Andrew B, Campa Michael, Gottlin Elizabeth B, Li Huihua, Saxena Ruchi, He You Wen, Antonia Scott, Patz Edward F Jr

Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases

脑转移瘤的症状性坏死:双重免疫检查点抑制剂联合放射外科治疗

Vaios, Eugene J; Shenker, Rachel F; Hendrickson, Peter G; Wan, Zihan; Niedzwiecki, Donna; Carpenter, David; Floyd, Warren; Winter, Sebastian F; Shih, Helen A; Dietrich, Jorg; Wang, Chunhao; Salama, April K S; Clarke, Jeffrey M; Allen, Karen; Sperduto, Paul; Mullikin, Trey; Kirkpatrick, John P; Floyd, Scott R; Reitman, Zachary J

Practical management of adverse events in patients receiving tarlatamab, a delta-like ligand 3-targeted bispecific T-cell engager immunotherapy, for previously treated small cell lung cancer

对于既往接受过治疗的小细胞肺癌患者,使用靶向δ样配体3的双特异性T细胞衔接器免疫疗法tarlatamab治疗时,不良事件的实用管理

Sands, Jacob M; Champiat, Stéphane; Hummel, Horst-Dieter; Paulson, Kelly G; Borghaei, Hossein; Alvarez, Jean Bustamante; Carbone, David P; Carlisle, Jennifer W; Choudhury, Noura J; Clarke, Jeffrey M; Gadgeel, Shirish M; Izumi, Hiroki; Navarro, Alejandro; Lau, Sally C M; Lammers, Philip E; Huang, Shuang; Hamidi, Ali; Mukherjee, Sujoy; Owonikoko, Taofeek K

Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives

早期可手术切除的非小细胞肺癌的新辅助、围手术期和辅助免疫治疗:最新进展和未来展望

Gathers, Diamone; Oswalt, Cameron; Alder, Laura; Chen, Kevin; Higgins, Jordyn P; Clarke, Jeffrey M; Oduah, Eziafa I

Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell Lung Cancer Brain Metastases

黑色素瘤和非小细胞肺癌脑转移患者接受双重免疫检查点阻断联合立体定向放射外科治疗的长期颅内疗效

Vaios, Eugene J; Shenker, Rachel F; Hendrickson, Peter G; Wan, Zihan; Niedzwiecki, Donna; Winter, Sebastian F; Shih, Helen A; Dietrich, Jorg; Wang, Chunhao; Salama, April K S; Clarke, Jeffrey M; Allen, Karen; Sperduto, Paul; Mullikin, Trey; Kirkpatrick, John P; Floyd, Scott R; Reitman, Zachary J